BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26559280)

  • 41. Patterns of recurrence after low-dose postoperative radiotherapy for head and neck squamous cell carcinoma.
    Makino W; Heianna J; Ishikawa K; Kusada T; Maemoto H; Ariga T; Matayoshi A; Nakasone T; Hirakawa H; Agena S; Yamashita Y; Maeda H; Murayama S
    J Egypt Natl Canc Inst; 2021 Dec; 33(1):40. PubMed ID: 34927227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort study.
    Wilbers J; Dorresteijn LD; Haast R; Hoebers FJ; Kaanders JH; Boogerd W; van Werkhoven ED; Nowee ME; Hansen HH; de Korte CL; Kappelle AC; van Dijk EJ
    Radiother Oncol; 2014 Dec; 113(3):359-63. PubMed ID: 25466374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
    Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
    Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of dementia in patients with non-haemorrhagic stroke receiving acupuncture treatment: a nationwide matched cohort study from Taiwan's National Health Insurance Research Database.
    Shih CC; Yeh CC; Hu CJ; Lane HL; Tsai CC; Chen TL; Liao CC
    BMJ Open; 2017 Jul; 7(6):e013638. PubMed ID: 28679673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort.
    Kim JK; Verma N; McBride S; Riaz N; Boyle JO; Spielsinger D; Sabol C; Waldenberg T; Brinkman T; Alektiar K; Lee NY; Tsai CJ
    Laryngoscope; 2020 Jan; 130(1):120-127. PubMed ID: 30892716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
    Paulino AC; Simon JH; Zhen W; Wen BC
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.
    Huang WK; Liu CH; Pang ST; Liu JR; Chang JW; Liaw CC; Hsu CL; Lin YC; See LC
    JAMA Netw Open; 2020 Aug; 3(8):e2015189. PubMed ID: 32865575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
    Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD
    Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
    Lin YC; Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Kao CH
    J Nucl Med; 2015 Feb; 56(2):183-9. PubMed ID: 25613534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
    Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect on long-term survival of psychiatric disorder, inflammation, malnutrition, and radiotherapy-related toxicity in patients with locally advanced head and neck cancer.
    Unal D; Eroglu C; Ozsoy SD; Besirli A; Orhan O; Kaplan B
    J BUON; 2015; 20(3):886-93. PubMed ID: 26214644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years.
    Dorresteijn LD; Kappelle AC; Boogerd W; Klokman WJ; Balm AJ; Keus RB; van Leeuwen FE; Bartelink H
    J Clin Oncol; 2002 Jan; 20(1):282-8. PubMed ID: 11773180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of first and recurrent stroke in childhood cancer survivors treated with cranial and cervical radiation therapy.
    Mueller S; Sear K; Hills NK; Chettout N; Afghani S; Gastelum E; Haas-Kogan D; Fullerton HJ
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):643-8. PubMed ID: 23623405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.